Stock Region Penny Picks
Stock Region Watchlist Newsletter - Thursday, July 17, 2025
Stock Region Watchlist Newsletter - Thursday, July 17, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always do your own research and consult with a financial advisor before making investment decisions. Stocks are volatile, and past performance is not indicative of future results.
Hello, Stock Region Family!
Buckle up, because today’s watchlist is packed with exciting updates, groundbreaking partnerships, and a few eyebrow-raising moves in the market. Let’s dive in and see what’s making waves today!
$IMRN - Immuron
FY25 global sales exceed projection, up 49% on prior year
Immuron is flexing its muscles with a stellar 49% increase in global sales. This kind of growth is what dreams are made of for long-term investors. If you’re holding $IMRN, you’re probably smiling ear to ear right now. Could this momentum carry forward? Time will tell, but it’s definitely one to keep on your radar.
$SXTP - 60 Degrees Pharmaceuticals
Partners with Tulane University to study Tafenoquine against Lyme and Bartonella bacteria
This partnership screams potential. Tackling Lyme disease and Bartonella bacteria is no small feat, and if $SXTP can make headway here, it could be a game-changer in the biotech space. Keep an eye on this one—it’s got “breakthrough” written all over it.
$RCKT - Rocket Pharmaceuticals
FDA RMAT designation for RP-A601 gene therapy
Rocket Pharmaceuticals is living up to its name, shooting for the stars with this FDA designation. Gene therapy for PKP2-Arrhythmogenic Cardiomyopathy is a niche but critical area. This could be a major win for patients and investors alike.
$LCID - Lucid
Two big updates: Reverse stock split plan and autonomous robotaxi partnership with Nuro and Uber
Lucid is making bold moves. The reverse stock split might raise some eyebrows, but the partnership with Nuro and Uber for next-gen robotaxis is undeniably exciting. Autonomous vehicles are the future, and $LCID is positioning itself as a key player.
$BTOG - Bit Origin
Secures $500M to launch Dogecoin Treasury
Dogecoin? Really? Love it or hate it, $BTOG is betting big on the meme coin. This move is bold, risky, and, let’s be honest, a little wild. But hey, fortune favors the brave, right?
$VLCN - Volcon
Announces $500M private placement for Bitcoin Treasury strategy
Another crypto play, but this time with Bitcoin. $VLCN is diving headfirst into the digital asset pool. With $500M on the table, they’re not messing around. Is this the start of a trend for companies diversifying into crypto?
$ZENA - ZenaTech
Releases video of ZenaDrone's IQ Nano Indoor Inventory AI Drone
AI and drones? Yes, please! ZenaTech is blending cutting-edge tech with practical applications. The US defense and government interest adds a layer of credibility. This one feels like it’s just getting started.
$ABVE
Up 79% on the day at $3.01 with 76M volume
$ABVE is on fire today! A 79% jump and massive volume? This could be a short squeeze, a breakout, or just pure market hype. Either way, it’s worth watching closely.
$HOLO - MicroCloud Hologram Inc.
Invests $200M in Bitcoin and crypto-related securities
Another company diving into crypto, but with a twist—derivatives. $HOLO is playing the long game here, and their $34.67M cumulative investment income shows they know what they’re doing.
$DTIL - Precision BioSciences
FDA Orphan Drug Designation for PBGENE-DMD
Precision BioSciences is making strides in treating Duchenne muscular dystrophy. This FDA designation is a big deal and could pave the way for future breakthroughs.
$AMBC - Ambac
Hearing scheduled for sale of legacy business
Mark your calendars for August 4th. This hearing could be a pivotal moment for $AMBC. Stay tuned!
$YHC - LQR House
Signals shift toward digital assets with crypto investor support
$YHC is signaling a bold new direction. With zero debt and over $20M raised through its ATM, they’re in a strong position to pivot. Could this be the start of something big?
$TELO - Telomir
Telomir-1 outperforms chemotherapy in prostate cancer cells
This is huge. If Telomir-1 can deliver on its promise, it could revolutionize cancer treatment. $TELO is one to watch for the long haul.
$GCTK
Volume spike to 7.25
Something’s brewing with $GCTK. A volume spike like this often signals big news or a major move. Keep your eyes peeled.
$BZAI - Blaize
Secures contract for hybrid AI infrastructure across Asia
AI is the future, and $BZAI is making moves to dominate in Asia. This contract could be a game-changer for their growth trajectory.
Today’s watchlist is a rollercoaster of innovation, bold moves, and market surprises. From biotech breakthroughs to crypto gambles, there’s no shortage of excitement. Remember, the stock market is as unpredictable as ever, so tread carefully and invest wisely.
Disclaimer: This newsletter is not financial advice. Always consult with a professional before making investment decisions.